Research Focus

Former Employee. Biostat/Epidemiology; NE Agency Contingent

Recent additions – View all

1. Methodologic approach to defining comorbidities in a cohort of patients with cancer: An example in the optimal breast cancer chemotherapy dosing study

   Journal Article

   Wang, P.; O'Connell, K.; Bhimani, J.; Blinder, V.; Burganowski, R.; Ergas, I. J.; Gallagher, G. B.; Griggs, J. J.; Heon, N.; Kolevska, T.; more...
   JCO Clinical Cancer Informatics (2025)

   Fulltext@MSK | Save
2. Patient characteristics associated with intended nonguideline chemotherapy in women with stage I to IIIA breast cancer

   Journal Article

   Bhimani, J.; O'Connell, K.; Persaud, S.; Blinder, V.; Burganowski-Doud, R. P.; Ergas, I. J.; Gallagher, G. B.; Griggs, J. J.; Heon, N.; Kolevska, T.; more...
   Cancer Epidemiology Biomarkers and Prevention (2024)

   Fulltext@MSK | Save
3. Patient characteristics associated with delayed time to adjuvant chemotherapy among women treated for stage I–IIIA breast cancer

   Journal Article

   Bhimani, J.; O'Connell, K.; Persaud, S.; Blinder, V.; Burganowski, R.; Ergas, I. J.; Foley, M. J.; Gallagher, G. B.; Griggs, J. J.; Heon, N.; more...
   International Journal of Cancer (2024)

   Fulltext@MSK | Save